Skip to main content
Top
Published in: Current Treatment Options in Cardiovascular Medicine 4/2010

01-08-2010 | Prevention

Omega-3 Fatty Acids for Cardiovascular Disease Prevention

Authors: Andrew Paul DeFilippis, MD, MSc, Michael J. Blaha, MD, MPH, Terry A. Jacobson, MD

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 4/2010

Login to get access

Opinion statement

Major dietary sources of omega-3 fatty acids are fish containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as well as nuts, seeds, and vegetable oils containing α-linolenic acid (ALA). Omega-3 fatty acids, especially those derived from marine sources, may be a useful tool for the primary and secondary prevention of cardiovascular disease. Omega-3s exert their cardioprotective effects through multiple mechanisms, including reducing arrhythmias and altering production of prostaglandins, which reduces inflammation and improves platelet and endothelial function. To date, no serious adverse effects of omega-3s have been identified, despite extensive study. In adults, any potential harm from mercury exposure from consuming fish rich in omega-3s is outweighed by the proven cardiovascular benefits of eating fish. Concerns over increased bleeding complications have not materialized despite the increased concomitant use of aspirin and clopidogrel. We recommend one serving (200–400 g) of fatty fish two times per week and a diet that includes foods rich in ALA for the primary prevention of cardiovascular disease. We recommend one serving (200–400 g) of fatty fish or a fish oil supplement containing 900 mg of EPA + DHA every day and a diet rich in ALA for patients with known cardiovascular disease or congestive heart failure.
Literature
1.
go back to reference Dyerberg J, Bang HO, Stoffersen E, et al.: Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978, 2(8081):117–119.CrossRefPubMed Dyerberg J, Bang HO, Stoffersen E, et al.: Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978, 2(8081):117–119.CrossRefPubMed
2.
go back to reference Albert CM, Campos H, Stampfer MJ, et al.: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346(15):1113–1118.CrossRefPubMed Albert CM, Campos H, Stampfer MJ, et al.: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346(15):1113–1118.CrossRefPubMed
3.
go back to reference Albert CM, Hennekens CH, O’Donnell CJ, et al.: Fish consumption and risk of sudden cardiac death. JAMA 1998, 279(1):23–28.CrossRefPubMed Albert CM, Hennekens CH, O’Donnell CJ, et al.: Fish consumption and risk of sudden cardiac death. JAMA 1998, 279(1):23–28.CrossRefPubMed
4.
go back to reference Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999, 354(9177):447–455 [Published erratum appears in Lancet 2001, 357(9256):642]. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999, 354(9177):447–455 [Published erratum appears in Lancet 2001, 357(9256):642].
5.
go back to reference Ascherio A, Rimm EB, Stampfer MJ, et al.: Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995, 332(15):977–982.CrossRefPubMed Ascherio A, Rimm EB, Stampfer MJ, et al.: Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995, 332(15):977–982.CrossRefPubMed
7.
go back to reference Kris-Etherton PM, Harris WS, Appel LJ, American Heart Association: Nutrition C: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106(21):2747–2757 [Published erratum appears in Circulation 2003, 107(3):512].CrossRefPubMed Kris-Etherton PM, Harris WS, Appel LJ, American Heart Association: Nutrition C: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106(21):2747–2757 [Published erratum appears in Circulation 2003, 107(3):512].CrossRefPubMed
8.
go back to reference Kromhout D, Bosschieter EB, de Lezenne Coulander C: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985, 312(19):1205–1209.PubMedCrossRef Kromhout D, Bosschieter EB, de Lezenne Coulander C: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985, 312(19):1205–1209.PubMedCrossRef
9.•
go back to reference Yokoyama M, Origasa H, Matsuzaki M, et al.; Japan EPA lipid intervention study (JELIS) Investigators: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369(9567):1090–1098.CrossRefPubMed Yokoyama M, Origasa H, Matsuzaki M, et al.; Japan EPA lipid intervention study (JELIS) Investigators: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369(9567):1090–1098.CrossRefPubMed
10.
go back to reference Lev ES, Harel A, Mager N, et al.: Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. J Am Coll Cardiol 2010, 55(2):114.CrossRefPubMed Lev ES, Harel A, Mager N, et al.: Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. J Am Coll Cardiol 2010, 55(2):114.CrossRefPubMed
11.
go back to reference Farzaneh-Far R, Harris WS, Garg S, et al.: Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009, 205(2):538–543.CrossRefPubMed Farzaneh-Far R, Harris WS, Garg S, et al.: Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009, 205(2):538–543.CrossRefPubMed
12.
go back to reference Farzaneh-Far R, Lin J, Epel ES, et al.: Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 303(3):250–257 Farzaneh-Far R, Lin J, Epel ES, et al.: Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 303(3):250–257
13.
go back to reference He K, Liu K, Daviglus ML, et al.: Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 2009, 103(9):1238–1243.CrossRefPubMed He K, Liu K, Daviglus ML, et al.: Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 2009, 103(9):1238–1243.CrossRefPubMed
14.
go back to reference Lopez-Garcia E, Schulze MB, Manson JE, et al.: Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004, 134(7):1806–1811.PubMed Lopez-Garcia E, Schulze MB, Manson JE, et al.: Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004, 134(7):1806–1811.PubMed
15.
go back to reference Micallef MA, Munro IA, Garg ML: An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr 2009, 63(9):1154–1156.CrossRefPubMed Micallef MA, Munro IA, Garg ML: An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr 2009, 63(9):1154–1156.CrossRefPubMed
16.
go back to reference Pischon T, Hankinson SE, Hotamisligil GS, et al.: Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108(2):155–160.CrossRefPubMed Pischon T, Hankinson SE, Hotamisligil GS, et al.: Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108(2):155–160.CrossRefPubMed
17.
go back to reference Kris-Etherton PM, Grieger JA, Etherton TD: Dietary reference intakes for DHA and EPA. Prostaglandins Leukot Essent Fat Acids 2009, 81(2–3):99–104.CrossRef Kris-Etherton PM, Grieger JA, Etherton TD: Dietary reference intakes for DHA and EPA. Prostaglandins Leukot Essent Fat Acids 2009, 81(2–3):99–104.CrossRef
18.
go back to reference Lavie CJ, Milani RV, Mehra MR, Ventura HO: Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009, 54(7):585–594.CrossRefPubMed Lavie CJ, Milani RV, Mehra MR, Ventura HO: Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009, 54(7):585–594.CrossRefPubMed
19.•
go back to reference Mozaffarian D: Fish, mercury, selenium and cardiovascular risk: current evidence and unanswered questions. Int J Environ Res Public Health 2009, 6(6):1894–1916.CrossRefPubMed Mozaffarian D: Fish, mercury, selenium and cardiovascular risk: current evidence and unanswered questions. Int J Environ Res Public Health 2009, 6(6):1894–1916.CrossRefPubMed
20.
go back to reference Rawn DF, Breakell K, Verigin V, et al.: Persistent organic pollutants in fish oil supplements on the Canadian market: polychlorinated biphenyls and organochlorine insecticides. J Food Sci 2009, 74(1):T14–T19.CrossRefPubMed Rawn DF, Breakell K, Verigin V, et al.: Persistent organic pollutants in fish oil supplements on the Canadian market: polychlorinated biphenyls and organochlorine insecticides. J Food Sci 2009, 74(1):T14–T19.CrossRefPubMed
21.
go back to reference Burdge G: Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 2004, 7(2):137–144.CrossRefPubMed Burdge G: Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 2004, 7(2):137–144.CrossRefPubMed
22.
go back to reference DeFilippis AP, Harper CR, Cotsonis GA, Jacobson TA: Effect of baseline plasma fatty acids on eicosapentaenoic acid levels in individuals supplemented with alpha-linolenic acid. Int J Food Sci Nutr 2009, 60(Suppl 5):28–37.CrossRefPubMed DeFilippis AP, Harper CR, Cotsonis GA, Jacobson TA: Effect of baseline plasma fatty acids on eicosapentaenoic acid levels in individuals supplemented with alpha-linolenic acid. Int J Food Sci Nutr 2009, 60(Suppl 5):28–37.CrossRefPubMed
23.
go back to reference Emken EA, Adlof RO, Gulley RM: Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1994, 1213(3):277–288.PubMed Emken EA, Adlof RO, Gulley RM: Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1994, 1213(3):277–288.PubMed
24.
go back to reference Gerster H: Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int J Vitam Nutr Res 1998, 68(3):159–173.PubMed Gerster H: Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int J Vitam Nutr Res 1998, 68(3):159–173.PubMed
25.
go back to reference Goyens PL, Spilker ME, Zock PL, et al.: Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 2006, 84(1):44–53.PubMed Goyens PL, Spilker ME, Zock PL, et al.: Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 2006, 84(1):44–53.PubMed
26.
go back to reference Harper CR, Edwards MJ, DeFilipis AP, Jacobson TA: Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J Nutr 2006, 136(1):83–87.PubMed Harper CR, Edwards MJ, DeFilipis AP, Jacobson TA: Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J Nutr 2006, 136(1):83–87.PubMed
27.
go back to reference Layne KS, Goh YK, Jumpsen JA, et al.: Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels. J Nutr 1996, 126(9):2130–2140.PubMed Layne KS, Goh YK, Jumpsen JA, et al.: Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels. J Nutr 1996, 126(9):2130–2140.PubMed
28.
go back to reference Sprecher H: An update on the pathways of polyunsaturated fatty acid metabolism. Curr Opin Clin Nutr Metab Care 1999, 2(2):135–138.CrossRefPubMed Sprecher H: An update on the pathways of polyunsaturated fatty acid metabolism. Curr Opin Clin Nutr Metab Care 1999, 2(2):135–138.CrossRefPubMed
29.
go back to reference Mozaffarian D, Ascherio A, Hu FB, et al.: Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005, 111(2):157–164.CrossRefPubMed Mozaffarian D, Ascherio A, Hu FB, et al.: Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005, 111(2):157–164.CrossRefPubMed
31.
go back to reference Weber PC: Clinical studies on the effects of n-3 fatty acids on cells and eicosanoids in the cardiovascular system. J Intern Med Suppl 1989, 225(731):61–68. Weber PC: Clinical studies on the effects of n-3 fatty acids on cells and eicosanoids in the cardiovascular system. J Intern Med Suppl 1989, 225(731):61–68.
32.
go back to reference Weber PC, Leaf A: Cardiovascular effects of omega 3 fatty acids. Atherosclerosis risk factor modification by omega 3 fatty acids. World Rev Nutr Diet 1991, 66:218–232.PubMed Weber PC, Leaf A: Cardiovascular effects of omega 3 fatty acids. Atherosclerosis risk factor modification by omega 3 fatty acids. World Rev Nutr Diet 1991, 66:218–232.PubMed
33.
go back to reference Simopoulos AP: Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999, 70(3 Suppl):560S–569S.PubMed Simopoulos AP: Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999, 70(3 Suppl):560S–569S.PubMed
34.
35.
go back to reference Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342(12):836–843.CrossRefPubMed Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342(12):836–843.CrossRefPubMed
36.
go back to reference Patrono C: The PGH-synthase system and isozyme-selective inhibition. J Cardiovasc Pharmacol 2006, 47(Suppl 1):S1–S6.CrossRefPubMed Patrono C: The PGH-synthase system and isozyme-selective inhibition. J Cardiovasc Pharmacol 2006, 47(Suppl 1):S1–S6.CrossRefPubMed
37.
go back to reference Patrono C, Falco A, Davi G: Isoprostane formation and inhibition in atherothrombosis. Curr Opin Pharmacol 2005, 5(2):198–203.CrossRefPubMed Patrono C, Falco A, Davi G: Isoprostane formation and inhibition in atherothrombosis. Curr Opin Pharmacol 2005, 5(2):198–203.CrossRefPubMed
38.
go back to reference Needleman P, Raz A, Minkes MS, et al.: Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci U S A 1979, 76(2):944–948.CrossRefPubMed Needleman P, Raz A, Minkes MS, et al.: Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci U S A 1979, 76(2):944–948.CrossRefPubMed
39.
go back to reference Engstrom K, Wallin R, Saldeen T: Effect of low-dose aspirin in combination with stable fish oil on whole blood production of eicosanoids. Prostaglandins Leukot Essent Fat Acids 2001, 64(6):291–297.CrossRef Engstrom K, Wallin R, Saldeen T: Effect of low-dose aspirin in combination with stable fish oil on whole blood production of eicosanoids. Prostaglandins Leukot Essent Fat Acids 2001, 64(6):291–297.CrossRef
40.
go back to reference Kramer HJ, Stevens J, Grimminger F, Seeger W: Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. Biochem Pharmacol 1996, 52(8):1211–1217.CrossRefPubMed Kramer HJ, Stevens J, Grimminger F, Seeger W: Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. Biochem Pharmacol 1996, 52(8):1211–1217.CrossRefPubMed
41.
go back to reference Calo L, Bianconi L, Colivicchi F, et al.: N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005, 45(10):1723–1728.CrossRefPubMed Calo L, Bianconi L, Colivicchi F, et al.: N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005, 45(10):1723–1728.CrossRefPubMed
42.
go back to reference Reiffel JA, McDonald A: Antiarrhythmic effects of omega-3 fatty acids. Am J Cardiol 2006, 98(4A):50i–60i.CrossRefPubMed Reiffel JA, McDonald A: Antiarrhythmic effects of omega-3 fatty acids. Am J Cardiol 2006, 98(4A):50i–60i.CrossRefPubMed
43.
go back to reference Senges S: Randomized trial of omega-3 fatty acids on top of modern therapy after acute myocardial infarction: the OMEGA trial. Presented at the American College of Cardiology 58th Annual Scientific Session. Orlando, FL: March 29–31, 2009. Senges S: Randomized trial of omega-3 fatty acids on top of modern therapy after acute myocardial infarction: the OMEGA trial. Presented at the American College of Cardiology 58th Annual Scientific Session. Orlando, FL: March 29–31, 2009.
44.•
go back to reference Tavazzi L, Maggioni AP, Marchioli R, et al.: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372(9645):1223–1230.CrossRefPubMed Tavazzi L, Maggioni AP, Marchioli R, et al.: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372(9645):1223–1230.CrossRefPubMed
45.
go back to reference Brouwer IA, Raitt MH, Dullemeijer C, et al.: Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J 2009, 30(7):820–826.CrossRefPubMed Brouwer IA, Raitt MH, Dullemeijer C, et al.: Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J 2009, 30(7):820–826.CrossRefPubMed
46.
go back to reference Mozaffarian D, Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296(15):1885–1899.CrossRefPubMed Mozaffarian D, Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296(15):1885–1899.CrossRefPubMed
47.
go back to reference Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP: Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 2009, 120(23):2315–2321.CrossRefPubMed Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP: Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 2009, 120(23):2315–2321.CrossRefPubMed
48.
go back to reference Macchia A, Varini S, Grancelli H, et al.: The rationale and design of the FORomegaARD Trial: a randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation. Am Heart J 2009, 157(3):423–427.CrossRefPubMed Macchia A, Varini S, Grancelli H, et al.: The rationale and design of the FORomegaARD Trial: a randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation. Am Heart J 2009, 157(3):423–427.CrossRefPubMed
49.
go back to reference Pratt CM, Reiffel JA, Ellenbogen KA, et al.: Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study. Am Heart J 2009, 158(2):163–169.e161–163. Pratt CM, Reiffel JA, Ellenbogen KA, et al.: Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study. Am Heart J 2009, 158(2):163–169.e161–163.
51.
go back to reference US Food and Drug Administration: Center for Food Safety and Applied Nutrition. Washington, DC: Department of Health and Human Services; 2004. US Food and Drug Administration: Center for Food Safety and Applied Nutrition. Washington, DC: Department of Health and Human Services; 2004.
52.
go back to reference Watson PD, Joy PS, Nkonde C, et al.: Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel—versus—aspirin + clopidogrel in patients with cardiovascular disease. Am J Cardiol 2009, 104(8):1052–1054.CrossRefPubMed Watson PD, Joy PS, Nkonde C, et al.: Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel—versus—aspirin + clopidogrel in patients with cardiovascular disease. Am J Cardiol 2009, 104(8):1052–1054.CrossRefPubMed
53.
go back to reference Hites RA, Foran JA, Carpenter DO, et al.: Global assessment of organic contaminants in farmed salmon. Science 2004, 303(5655):226–229.CrossRefPubMed Hites RA, Foran JA, Carpenter DO, et al.: Global assessment of organic contaminants in farmed salmon. Science 2004, 303(5655):226–229.CrossRefPubMed
54.
go back to reference Foran SE, Flood JG, Lewandrowski KB: Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med 2003, 127(12):1603–1605.PubMed Foran SE, Flood JG, Lewandrowski KB: Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med 2003, 127(12):1603–1605.PubMed
55.
go back to reference National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143–3421. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143–3421.
56.
go back to reference Bays HE, McKenney J, Maki KC, et al.: Effects of prescription omega-3-acid ethyl esters on non–high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin. Mayo Clin Proc 2010, 85(2):122–128.CrossRefPubMed Bays HE, McKenney J, Maki KC, et al.: Effects of prescription omega-3-acid ethyl esters on non–high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin. Mayo Clin Proc 2010, 85(2):122–128.CrossRefPubMed
57.
go back to reference Davidson MH, Stein EA, Bays HE, et al.: Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther 2007, 29(7):1354–1367.CrossRefPubMed Davidson MH, Stein EA, Bays HE, et al.: Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther 2007, 29(7):1354–1367.CrossRefPubMed
Metadata
Title
Omega-3 Fatty Acids for Cardiovascular Disease Prevention
Authors
Andrew Paul DeFilippis, MD, MSc
Michael J. Blaha, MD, MPH
Terry A. Jacobson, MD
Publication date
01-08-2010
Publisher
Current Science Inc.
Published in
Current Treatment Options in Cardiovascular Medicine / Issue 4/2010
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-010-0079-4

Other articles of this Issue 4/2010

Current Treatment Options in Cardiovascular Medicine 4/2010 Go to the issue